Scienture (SCNX)
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous s...
- Open
- 0.3100
- High
- 0.3218
- Low
- 0.3100
- Prev. Close
- 0.3132
- Volume
- 297.77K
- Turnover
- 94.36K
- Avg Price
- 0.3169
- Bid/Ask Ratio
- --
- Amplitude
- 3.77%
- 52wk High
- 2.6000
- Volume Ratio
- 0.92
- Turnover Ratio
- 0.90%
Scienture Analyst Rating
View moreForecast & Rating
Aug 14, 2026Price forecast
$1.50378.47%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Weekly Review · 12 hours ago
Weekly Recap | Scienture -9.89%, consensus target above spot
- Global Report · Sep 15 at 10:12 AM
M&A Talks and AI-Driven Revenue Beats Highlight Cross-Sector Moves
- TradingView · Sep 14 at 08:13 PM
Scienture posts revised investor presentation, will present to analysts and investors
- Quartr · Sep 14 at 08:00 PM
SCNX: Rapid revenue growth and FDA-approved launches highlight a strong specialty pharma pipeline
- StockTitan · Sep 9 at 04:55 AM
SCIENTURE to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14, 2026 | SCNX Stock News
